Skip to content
  1. Home/
  2. Latest news/
  3. Johnson & Johnson takes a top spot on the 2017 Thomson Reuters Diversity & Inclusion Index
A photo of a woman leading a meeting

Johnson & Johnson takes a top spot on the 2017 Thomson Reuters Diversity & Inclusion Index

The company came in at #2 on the list of the 100 most diverse and inclusive workplaces around the world.

Johnson & Johnson has secured the #2 ranking on the 2017 Thomson Reuters Diversity & Inclusion Index.

The index selects the top 100 publicly traded companies out of a pool of more than 6,000, based on performance across such categories as diversity, inclusion and people development.

Johnson & Johnson’s positioning—up two spots from last year—reinforces its long commitment to creating a “culture of belonging” among its more than 130,000 employees worldwide, according to Chief Diversity & Inclusion Officer Wanda Bryant Hope.

“Johnson & Johnson is proud to be recognized as #2 on the Thomson Reuters Diversity & Inclusion Index,” she says. “We know the best way to reach the patients, doctors and consumers we serve—whose demographics are rapidly changing—is by having a workforce that reflects their diversity. The commitment we have to inclusion is a key element in further enabling our people to be themselves, deliver their best and change the world.”


Why a Diverse Workforce Is a Priority for Us

Johnson & Johnson prides itself on its diversity & inclusion initiatives, which helped us top the Thomson Reuters list.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.